Organisation paid for research Program year 2024 Source: CMS Open Payments

Andover Research Eye

Neither a doctor nor a teaching hospital

Research payments

$926,525

22 payments

Through program year 2024, Andover Research Eye is reported as receiving $926,525 in research payments, across 22 payments.

By program year

3 rows

Year	Kind	Amount	Payments
2024	Research	$128,272	2
2023	Research	$141,580	10
2022	Research	$656,674	10

Breakdown

Who paid Research payments · program years 2022–2024

Alcon Research LLC $877,028 19 payments
Oyster Point Pharma, Inc. $49,497 3 payments

Studies the money was for Research payments · program years 2022–2024

Comparing the Efficacy of Pataday Once Daily Relief Extra Strength to Claritin in Reducing Ocular Itching in Subjects with Allergic Conjunctivitis $201,795 3 payments
Comparing the Efficacy of Pataday Once Daily Relief Extra Strength to Flonase Sensimist Allergy Relief in Reducing Ocular Itching in Subjects with Allergic Conjunctivitis $185,570 3 payments
How does Systane Hydration PF impact functional visual acuity, measured in real-time between blinks, in dry eye patients $172,533 3 payments
To evaluate the DT1 MF compared to symptomatic habitual MF reusable lens for endpoints related to comfortable wear and EOD comfort, vision and dryness symptoms $128,272 2 payments
How does Systane COMPLETE PF impact functional visual acuity, measured in real-time between blinks, in dry eye patients $93,273 2 payments
How does Systane COMPLETE PF impact functional visual acuity, measured in real-time between blinks, in dry eye patients? $93,272 1 payment
A Single-Center Randomized Open-Label Study Evaluating Oc-01 (Varenicline Solution) Nasal Spray Compared to Systane Preservative Free Eye Drops for Dynamic Objective and Quantifable Muco-Aqueous and Lipid Outcomes on Tear Film Imager Non-Invasive Nano Imaging Technology in Subjects With Dry Eye Disease $49,497 3 payments
A Phase 3 Study Evaluating the Safety and Efficacy of AR-15512, a Cold Thermoreceptor Modulator, for the Treatment of Dry Eye Disease $2,313 5 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.